Reported Adverse Events from the use of
Homeopropylaxis in FHCi HPx Programs

FHCi has been tracking remedy responses since 2013.




Definition: An adverse event is defined as a death, life - threatening adverse drug or device experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent disability/incapacity, or a congenital anomaly/birth defect.


Symptom presentation must have occurred within 1 week of HP x dosing be considered for review in our Adverse Events reporting process.

Patrons have three months to report an event. HPx Practitioners will interview and confirm the details of the Patrons Report and submit their own Practitioner Report. Both Reports will be reviewed and summarized by the FHCi Adverse Events Review Committee. Once reviewed they will be submitted to the FHCi Board for final review to either be a Published Adverse Event, or to be archived, within 60 days of original submission.

To date, not a single Adverse Event has been recorded.

Historical Registrations and research

Childhood Homeoprophyalxis: March 2009-(Launch date):

  • Long-Term Childhood HPx Program research registrants March 2009 - December 31, 2014: 682 Registrants, over total of 9300 doses for all Disease Nosodes delivered: (0) Adverse Events reported.
  • Total Patrons with who previously registered with FHCi for the Childhood program: July 2017 – (Launch date): (?) Registrants: (0) Adverse Events reported.

Coronavirus Homeoprophylaxis: February 2020- December 2022

  • Total participants in FHCi 2020 Coronavirus Nosode Research March 13, 2020 - April 25, 2020: 1169 Registrants, 3172 doses of Covid Nosode: (0) Adverse Events reported.
  • Total Patron Families (a family is one or more participants, up to 8) registered in Coronavirus prevention April 26, 2020 – December 1, 2022: 1350 Registrants: (0) Adverse Events reported.
  • From over 3000 consumers of the Coronavirus Nosode, with a possible 40,000-50,000 individual doses given, (0) Adverse Events have been reported.

All HPx Programs since (launch date)

  • Individual Patron Families registered on this platform: (27)
  • Number of doses of Nosodes recorded in the Patron Portal for all HPx Programs: (42)
  • Number of doses of Remedies recorded in the Patron Portal for all HPx Programs: (7)
  • Current Suspected Adverse Events under review: (0)

All HPx Program registrants: (16) Registrants: (0) Adverse Events Published.

  1. Healthy Biome HPx Program (1) registrants. (0) events published.
  2. Full Childhood Immunological HPx Program (1) registrants. (0) events published.
  3. Young Adult and College Prep HPx Program (1) registrants. (0) events published.
  4. Travel HPx Program (1) registrants. (0) events published.
  5. Healthy Sexuality and Pre-Procreation HPx Program (1) registrants. (0) events published.
  6. Healthy Pregnancy and Fetal Development HPx Program (1) registrants. (0) events published.
  7. Immune Health for Elders HPx Program (1) registrants. (0) events published.
  8. Single disease and Supplemental HPx (1) registrants. (0) events published.
  9. Group B Strep Prevention (1) registrants. (0) events published.
  10. HPx for Tick-Borne Illness (1) registrants. (0) events published.
  11. Homeo-Detox (0) registrants. (0) events published.
  12. Seasonal HPx (1) registrants. (0) events published.
  13. Influenza HPx (1) registrants. (0) events published.
  14. Pneumonia HPx (1) registrants. (0) events published.
  15. Measles HPx (1) registrants. (0) events published.
  16. Chickenpox HPx (1) registrants. (0) events published.
  17. Whooping Cough HPx (1) registrants. (0) events published.

Disclaimer

It is normal and expected that there would be mild immunological responses to HPx nosodes and remedies. These ARE NOT Adverse Events.

Adverse Event Liability: FHCi Patron Research Registrants accept the responsibilities and liabilities of their relationship within their HPx Practitioner’s Private Practice which is outside of the jurisdiction of FHCi. That relationship states there is a Member-to-Member agreement between Patron and Practitioner, and each person is responsible for their own actions, including their participation in research and ingestion of homeopathic nosodes under research.

FHCi is the developer of and oversees research of, provides education to, access to All HPx Programs.

FHCi stands by the safety, efficacy, and reliability of the HPx Programs and Homeopathic Protocols it develops. In addition, it operates in transparency for any possible Adverse Event. Accordingly, to serve the public, if a Patron believes they or their child have adversely reacted to an HPx remedy in any program or Homeopathic protocol in such a way that there may have been an Adverse Event then from within their Patron Portal they would submit an Adverse Event Report.

To report an adverse event please follow the directions in your Patron Portal.